Degree in Medicine and Surgery from the University of Barcelona, MIR specialist in General and Digestive Surgery, and in Oncological Surgery from George Washington University, Washington DC. PhD in Psychology and Behavioral Sciences, Newport University-Udine. Diploma in Business Administration and Management from IDEC-Pompeu Fabra. FUS-HIFU graduate from Chongqing University, China. Member of the board of the International Society of Therapeutic Ultrasound (ISTU) and the European Focused Ultrasound Foundation (EUFUS). President of the ISTU International Congress – EUFUS International Symposium in Barcelona in 2019. Principal investigator of the first clinical trial of Histotripsia in human liver tumors. Author of numerous conferences and publications, he has awarded prizes and grants for research in oncology, diagnostic imaging and results in health and health services.

For the past 12 years, Dr. Juan Jove Vidal learned the basics of focused ultrasound ablation and led the country’s first FUS-HIFU cancer unit. Since then, he has treated more than 200 patients with tumors of the liver, pancreas and soft tissue. As a scientific surgeon, he has focused his clinical research on the specific impact of ablation on advanced pancreatic and liver tumors, both locally and systemically through the action of immunity. As a doctor, he seeks the good of his patients with care focused on the transcendent dimension of the person.